Showing results (461-470 of 472) with videos related to

Sort By:
Pageof 48
Annals of Internal Medicine|August 29, 2022
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19, Angela J Rogers, Deborah Wentworth, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
The New England Journal of Medicine|December 28, 2020
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19, Jens D Lundgren, Birgit Grund, et al.
Kidney International|February 11, 2011
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohortsMarije van der Velde, Kunihiro Matsushita, Josef Coresh, et al.
Digital Discovery|August 21, 2025
Correction: Atomate2: modular workflows for materials scienceAlex M Ganose, Hrushikesh Sahasrabuddhe, Mark Asta, et al.
Digital Discovery|July 4, 2025
Atomate2: modular workflows for materials scienceAlex M Ganose, Hrushikesh Sahasrabuddhe, Mark Asta, et al.
Annals of Internal Medicine|December 20, 2021
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial, Jens D Lundgren, Birgit Grund, et al.
NEJM Evidence|May 22, 2023
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV InfectionJens D Lundgren, Abdel G Babiker, Shweta Sharma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2013
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive personsMargalida Rotger, Tracy R Glass, Thomas Junier, et al.
The Lancet. Respiratory Medicine|June 22, 2023
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trialSamuel M Brown, Christina E Barkauskas, Birgit Grund, et al.
Pageof 48